DiNuzzo Private Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Hold
102
﹤0.01% 251
2026
Q1
$14.2K Hold
102
﹤0.01% 233
2025
Q4
$12.5K Hold
102
﹤0.01% 245
2025
Q3
$11.5K Sell
102
-1
-1% -$114 ﹤0.01% 251
2025
Q2
$11.4K Sell
103
-4
-4% -$426 ﹤0.01% 241
2025
Q1
$12K Buy
107
+6
+6% +$619 ﹤0.01% 228
2024
Q4
$9.33K Hold
101
﹤0.01% 255
2024
Q3
$8.47K Buy
101
+3
+3% +$229 ﹤0.01% 278
2024
Q2
$6.72K Buy
98
+14
+17% +$934 ﹤0.01% 247
2024
Q1
$6.15K Buy
84
+1
+1% +$77 ﹤0.01% 232
2023
Q4
$6.72K Buy
+83
New +$6.46K ﹤0.01% 209

Other funds holding GILD

DiNuzzo Private Wealth's GILD Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Gilead Sciences (GILD) position steady in Q2 2026 at 102 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

DiNuzzo Private Wealth first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.2K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • DiNuzzo Private Wealth held 102 shares of Gilead Sciences worth $12.9K as of Q2 2026.
  • DiNuzzo Private Wealth left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #251 holding.
  • DiNuzzo Private Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's Gilead Sciences position peaked at $14.2K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.